ALLOPURINOL Tablets recalled over manufacturing violations
- Recall date
- January 26, 2022
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- CARDINAL HEALTHCARE recalls ALLOPURINOL Tablets, USP 300 MG 500 count Tablets per bottle, Rx only, Manufactured By: Dr. Reddy's Laboratories LA LLC…
- Recall number
- D-0164-2024
- FDA classification
- Class II
- Brand / firm
- CARDINAL HEALTHCARE
- Sold / distributed
- Nationwide USA
Why it was recalled
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
ALLOPURINOL Tablets, USP 300 MG 500 count Tablets per bottle, Rx only, Manufactured By: Dr. Reddy's Laboratories LA LLC, Shreveport, LA 71106. NDC: 55111-730-05
Get recall alerts
Free email alert whenever CARDINAL HEALTHCARE has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: CARDINAL HEALTHCARE